Pfizer CEO 'not sure' if its COVID-19 vaccine will prevent transmission after vaccination

Pfizer Inc’s CEO Albert Bourla has said that company is “t certain” if its COVID-19 vaccine candidate developed in collaboration with German drugmaker BioNTech SE prevented transmission of vel coronavirus. In a recent interview with NBC, when Bourla was asked by host if he will be able to transmit infection to or people if he is immunised, Pfizer CEO replied that “it needs to be examined”. Bourla’s response was one of highlights before special was released before special, just days after UK became world’s first country to give formal authorisation to Pfizer-BioNTech’s mRNA-based COVID-19 vaccine for mass rollout. 

“I think this is something that needs to be examined. We are t certain about that right w with what we kw,” Bourla told NBC.

UK on December 2 became first country in world to approve Pfizer-BioNtech COVID-19 vaccine candidate for widespre use. British regulator, MHRA has said that mRNA-based vaccine that has shown 95 per cent efficacy, is safe for mass roll out with immunisations in country starting "early next week" among high priority groups. Britain has reportedly alrey placed an order of 40 million doses of Pfizer-BioNTech's COVID-19 vaccine to provide double-dose immunisation to at least 20 million people. 

Re - Asian Stocks Lower After Pfizer Cuts Vaccine Shipment Plans'

Re - Pfizer CEO Urges Patience On Reopening Ecomies

UK's MHRA says ' corners cut' to approve vaccine

CEO of MHRA, Dr June Raine reiterated that “first” priority on immunisation is safety of citizens. Medicines and Healthcare products Regulatory ncy (MHRA) on December 2 assured that mRNA-based vaccine is 95 per cent effective “irrespective of , sex or race”. 

In news briefing, it was also informed that MHRA is working “hard” to deliver immunisation to all people starting from ones most vulnerable people. MHRA said that Pfizer-BioNTech COVID-19 vaccine is similar to or vaccines that are developed across world “and side effects are very low” with specific precautions or tests required before iculation. Raine expressed confidence in approval and assured that safety of vaccine has been scrutinised with ' stone being left unturned'.

Re - As UK Approves Pfizer-BioNtech's COVID-19 Vaccine, Here's Who Will Get Vaccinated First

Re - European Union Criticises Britain’s ‘hasty’ Approval Of Pfizer-BioNTech's COVID-19 Vaccine